.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Biologic Treatment Considerations for Asthma During the COVID-19 Pandemic and the Upcoming Flu Season

Latest News

Daridorexant Provides Positive Phase 3 Results in Adults with Insomnia

Pandemic-Trauma Stress Symptoms: Nightmares Significantly Increased Among Adults

AI Algorithm May Help Identify Eligibility for Diabetic Retinopathy Clinical Trials

View More News

Biologic Treatment Considerations for Asthma During the COVID-19 Pandemic and the Upcoming Flu Season

EP. 1: Overview of Uncontrolled Asthmatic Episode

EP. 2: Quality of Life and Increased Risk of Asthma Exacerbations

EP. 3: Over and Under Diagnosis of Asthma

EP. 4: Targeted Pathology for the Treatment of Asthma

EP. 5: Common Biomarkers of Asthma to Determine Treatment Efficacy

EP. 6: Raising Awareness Among Physicians Regarding Biologics

EP. 7: FDA Approved Agent Omalizumab for Asthma

EP. 8: Patient Factors That Determine the Use of Omalizumab in Asthma

EP. 9: IL-5 Inhibitors for Treatment of Asthma

EP. 10: Dupilumab for Moderate to Severe Asthma

Latest News